9TD Stock Chart & Stats
€0.25
€0.02(14.65%)
At close: 4:00 PM EST
€0.25
€0.02(14.65%)
Day’s Range― - ―
52-Week Range€0.08 - €0.36
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.97M
Enterprise Value€167.56
Total Cash (Recent Filing)€2.16M
Total Debt (Recent Filing)€32.86M
Price to Earnings (P/E)―
Beta-1.12
Next Earnings
May 13, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.90
Shares Outstanding26,956,257
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Arctic Bioscience AS News
9TD FAQ
What was Arctic Bioscience AS’s price range in the past 12 months?
Arctic Bioscience AS lowest stock price was €0.08 and its highest was €0.36 in the past 12 months.
What is Arctic Bioscience AS’s market cap?
Arctic Bioscience AS’s market cap is €6.97M.
When is Arctic Bioscience AS’s upcoming earnings report date?
Arctic Bioscience AS’s upcoming earnings report date is May 13, 2027 which is in 221 days.
How were Arctic Bioscience AS’s earnings last quarter?
Arctic Bioscience AS released its earnings results on Aug 27, 2026. The company reported -€0.062 earnings per share for the quarter.
Is Arctic Bioscience AS overvalued?
According to Wall Street analysts Arctic Bioscience AS’s price is currently Overvalued.
Does Arctic Bioscience AS pay dividends?
Arctic Bioscience AS does not currently pay dividends.
What is Arctic Bioscience AS’s EPS estimate?
Arctic Bioscience AS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arctic Bioscience AS have?
Arctic Bioscience AS has 26,956,257 shares outstanding.
What happened to Arctic Bioscience AS’s price movement after its last earnings report?
Arctic Bioscience AS reported an EPS of -€0.062 in its last earnings report. Following the earnings report the stock price went down -5.181%.
Which hedge fund is a major shareholder of Arctic Bioscience AS?
Currently, no hedge funds are holding shares in DE:9TD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Arctic Bioscience AS
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.